Differences in Clinical Outcomes between Luminal A and B Type Breast Cancers according to the St. Gallen Consensus 2013

PURPOSE: Human epidermal growth factor receptor 2 (HER2)-positive luminal B type comprises estrogen receptor (ER)-positive and HER2-positive cancers, and HER2-negative luminal B type comprises ER-positive cancers showing a Ki-67 labeling index ≥14% or progesterone receptor (PR) expression of <20%...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Hyo Jung, Jung, Soo Jin, Kim, Tae Hyun, Oh, Min Kyung, Yoon, Hye-Kyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Breast Cancer Society 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490264/
https://www.ncbi.nlm.nih.gov/pubmed/26155291
http://dx.doi.org/10.4048/jbc.2015.18.2.149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490264/
https://www.ncbi.nlm.nih.gov/pubmed/26155291
http://dx.doi.org/10.4048/jbc.2015.18.2.149

Ejemplares similares